Pfizer Inc. (PFE) New York Stock Exchange
42.16-0.11-0.26%
CloseJanuary 23, 2019

News: updated – 23-Jan 06:28


Reasons To Avoid J&J Now Relate To Other Safe Havens23-Jan 03:27(SeekingAlpha)

Background – JNJ as a high-P/E, overvalued name J&J ( JNJ ) reported Q4 and full-year numbers Monday. I ignore its attempts to adjust out amortization of such costly deals as the $30 B Actelion acquisition and focus on GAAP. Other relevant and recurring adjustments also get counted i…

Inovio Pharmaceuticals Is A Promising Pick In January 201923-Jan 01:59(SeekingAlpha)

Headquartered in Plymouth Meeting, Pennsylvania, United States, Inovio Pharmaceuticals ( INO ) is a development-stage biopharmaceutical company focused on developing therapies to prevent and treat multiple types of infectious diseases and cancer. The company is working on activation immunother…

UBS likes Lilly in premarket analyst action23-Jan 08:47(SeekingAlpha)

Alnylam Pharmaceuticals (NASDAQ: ALNY ) initiated with Neutral rating at UBS. More news on: Alnylam Pharmaceuticals, Inc., Atara Biotherapeutics, Elanco, Healthcare stocks news, Stocks on the move, , Read more …


Teva up 3% premarket on bullish call at UBS23-Jan 08:24(SeekingAlpha)

Teva Pharmaceutical Industries (NYSE: TEVA ) is up 3% premarket on modest volume on the heels of an upgrade to Buy with a $24 (28% upside) at UBS. Analyst Navin Jacob says the company is "too cheap to ignore," adding that the Street is over-estimating its debt paydown risk. Mor…